AVP and nephrogenic diabetes insipidus: Additionally, basal copeptin concentrations ≥21.4 pmol/L provided a reliable and noninvasive biomarker for nephrogenic diabetes insipidus (NDI), correctly identifying all confirmed cases in this study.